Hochschulschrift
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
30 cm
- Umfang
-
XVIII, 127Seiten
- Sprache
-
Englisch
- Anmerkungen
-
Illustrationen, Diagramme
Ruperto-Carola University of Heidelberg, Dissertation, 2018
- Klassifikation
-
Medizin, Gesundheit
Biowissenschaften, Biologie
- Schlagwort
-
Cancer immunotherapy
Bispecific T cell engager
Oncolytic virotherapy
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 13:39 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
Entstanden
- 2018
Ähnliche Objekte (12)
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Engineering targeted and cytokine-armed oncolytic measles viruses
Armed oncolytic measles vaccine virus for the treatment of hepatocellular carcinoma
Versatility of DARPin-targeted oncolytic measles viruses : safety, efficacy, and specificity
Oncolytic measles viruses to support BiTE and CAR T cell re-direction immunotherapies of solid tumors
Chemovirotherapy of malignant melanoma with a novel targeted and armed oncolytic measles virus
In vivo antitumor activity by dual stromal and tumor-targeted oncolytic measles viruses
Treatment of medulloblastoma with oncolytic measles viruses expressing the angiogenesis inhibitors endostatin and angiostatin
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Oncolytic viruses for cancer immunotherapy
Perspectives on immunotherapy via oncolytic viruses
Oncolytic viruses as therapeutic cancer vaccines
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Engineering targeted and cytokine-armed oncolytic measles viruses
Armed oncolytic measles vaccine virus for the treatment of hepatocellular carcinoma
Versatility of DARPin-targeted oncolytic measles viruses : safety, efficacy, and specificity
Oncolytic measles viruses to support BiTE and CAR T cell re-direction immunotherapies of solid tumors
Chemovirotherapy of malignant melanoma with a novel targeted and armed oncolytic measles virus
In vivo antitumor activity by dual stromal and tumor-targeted oncolytic measles viruses
Treatment of medulloblastoma with oncolytic measles viruses expressing the angiogenesis inhibitors endostatin and angiostatin
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Oncolytic viruses for cancer immunotherapy
Perspectives on immunotherapy via oncolytic viruses
Oncolytic viruses as therapeutic cancer vaccines
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Engineering targeted and cytokine-armed oncolytic measles viruses
Armed oncolytic measles vaccine virus for the treatment of hepatocellular carcinoma
Versatility of DARPin-targeted oncolytic measles viruses : safety, efficacy, and specificity
Oncolytic measles viruses to support BiTE and CAR T cell re-direction immunotherapies of solid tumors
Chemovirotherapy of malignant melanoma with a novel targeted and armed oncolytic measles virus
In vivo antitumor activity by dual stromal and tumor-targeted oncolytic measles viruses
Treatment of medulloblastoma with oncolytic measles viruses expressing the angiogenesis inhibitors endostatin and angiostatin
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Oncolytic viruses for cancer immunotherapy
Perspectives on immunotherapy via oncolytic viruses